Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,625,787
-
Share change
-
-15,125
-
Total reported value
-
$261,627,401
-
Price per share
-
$56.57
-
Number of holders
-
109
-
Value change
-
-$935,082
-
Number of buys
-
36
-
Number of sells
-
64
Institutional Holders of BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) as of Q1 2020
As of 31 Mar 2020,
BIOSPECIFICS TECHNOLOGIES CO - COM (BSTC) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,625,787 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Russell Investments Group, Ltd., RICE HALL JAMES & ASSOCIATES, LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, ROYCE & ASSOCIATES LP, STATE STREET CORP, and AQR CAPITAL MANAGEMENT LLC.
This page lists
109
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.